ScholarIQanswers from OpenAlex

Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy

PaperCitations, authors & open-access status

Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy have?

ScholarIQcitation count

Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy has 942 citations in the OpenAlex counts ScholarIQ stores.

When was Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy published?

ScholarIQyear

Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy has 2022 year in the ScholarIQ index.

What is the open-access status of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy?

ScholarIQoa status

Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy has green oa status in the ScholarIQ index.

What is the DOI of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy?

ScholarIQdoi

The DOI for Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy is on the source record.

What is the PMID of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy?

ScholarIQpmid

The PMID for Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy is on the source record.

What is the OpenAlex record for Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy?

ScholarIQopenalex

The OpenAlex for Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial